U.S. Venture Capital Rebounds in Q1 2025 — AI Leads, But Broader Momentum Builds

June 18, 2025

Venture capital activity in the U.S. is showing real signs of resurgence. According to recent data, U.S. VC firms deployed $91.5B in Q1 2025, marking a 116% year-over-year increase and the strongest quarterly total since late 2021.

While AI remains the dominant driver, a more nuanced picture is emerging: capital is once again flowing across multiple sectors, and the venture cycle is beginning to normalize after nearly two years of valuation resets and limited exits.

A Concentrated but Expanding Market

Much of Q1’s funding surge came from a handful of very large AI rounds — most notably OpenAI’s $40B raise — but it’s not purely a story of mega-deals. We’re also seeing renewed investor activity across fintech, healthtech, defense tech, and select consumer sectors.

Importantly, even with capital rebounding, deal counts remain down nearly 25% year-over-year. More dollars are chasing fewer companies — a clear sign that investors are still applying discipline, favoring companies with:

  • Strong revenue visibility
  • Efficient burn multiples
  • Defined paths to profitability

Chart1_Total_VC_Funding.png

Source

 

AI Still Commands Share — But It’s Pulling Other Sectors Forward

AI’s gravitational pull remains significant. Roughly 71% of all VC dollars in Q1 went to AI-related businesses, up from 62% last quarter. But AI’s momentum is also creating cross-sector opportunities that extend beyond pure model-building:

  • Fintech: AI-enabled underwriting, payments, and fraud prevention.
  • Healthcare: Diagnostics, patient engagement, and AI-powered drug discovery.
  • Defense & Cybersecurity: Autonomy, threat detection, and dual-use national security platforms.

Chart2_AI_Share_VC_Funding.png

Source

Sector Diversification Reemerges

While AI dominates absolute dollar flow, Q1 data also signals a healthy sector rotation as investor confidence extends to applied technologies:

Chart3_Funding_by_Sector.png

Source

Early-Stage Activity Still Dominates

Even as capital returns, later-stage deal activity remains constrained versus prior cycles. Many growth-stage companies continue to recalibrate pricing expectations or pursue structured rounds to secure capital.

Chart4_Deal_Count_by_Stage.png

Source

What This Means for Founders Raising in 2025

For founders entering the market now, several dynamics are worth watching:

  • Capital Is Available, But Not Cheap: Valuations are stabilizing but remain well off 2021 peaks.
  • Structure Remains Common: Many growth-stage rounds still include investor protections.
  • Preparation Is the Differentiator: Investors expect crisp narratives, clear metrics, and capital plans aligned to market realities.

Liquidity at the Top Drives Activity at the Bottom

Perhaps most importantly: liquidity is beginning to return. As IPOs, secondary transactions, and M&A restart, capital is circulating back to LPs, fueling new fund formation and opening up capacity for early- and growth-stage investments. This is how venture cycles reset and renew.

Supporting Founders in a Reopening Venture Cycle

At Fidelman & Co., we work closely with founders raising capital in today’s more selective—but reactivating—venture market. As funding flows return and investor expectations reset, we help startups run institutional-grade processes from day one.

Whether you’re preparing for a first raise or returning with a refined strategy, we’re here to help.

Contact Fidelman & Co. to explore how we support capital formation across seed, growth, and crossover stages.

More articles

The venture market enters 2026 with cautious optimism. After two years of valuation resets, tighter...
November 28, 2025
Seed hasn’t gone away—it’s just harder to do well. Rounds are bigger, ownership at entry...
November 13, 2025
The venture capital landscape is facing a fundamental reckoning. According to Roelof Botha of Sequoia...
October 31, 2025
After a muted first half, venture capital showed signs of life in Q3 2025 —...
October 16, 2025
Check out the recent episode of Insurtech with guest speaker Jeffrey Fidelman  In this episode,...
October 7, 2025
Q3 2025 finally delivered what the venture market had been waiting for: a meaningful reopening...
October 3, 2025